Refractory Immune-mediated Platelet Transfusion Refractoriness

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Refractory Immune-mediated Platelet Transfusion Refractoriness trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 1

NCT07072247

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

This single-arm, open-label exploratory trial aims to evaluate the safety, feasibility, and preliminary efficacy of RN1201 Injection in patients with antibody-m…

Location not specified9 participantsStarted 2025-07-10

Treatment: CD19 and BCMA-targeted allogeneic CAR-T cells